Streetbeat News

Products Services

RVYL

RYVYL is aligning its US operations to focus on diversifying into new vertical markets within its NEMS business unit. Christian Murray, Vice President of Revenue, has been promoted to Managing Director of NEMS effective July 15, 2024.

Portfolio Pulse from Benzinga Newsdesk

July 01, 2024 | 11:05 am

ALTR

Altair has announced its intention to acquire all outstanding capital stock of Metrics Design Automation, a Canadian company specializing in simulation as a service (SaaS) for semiconductor electronic functional simulation and design verification. The terms of the deal were not disclosed.

Portfolio Pulse from Benzinga Newsdesk

July 01, 2024 | 11:03 am

AEE

Ameren Missouri, a subsidiary of Ameren Corporation (NYSE:AEE), has filed a request with the Missouri Public Service Commission to adjust its electric base rates by mid-2025. The rate increase aims to fund major electric system upgrades and cleaner energy investments. If approved, the average residential customer would see an increase of about $17 per month.

Portfolio Pulse from Benzinga Newsdesk

July 01, 2024 | 10:56 am

EYEN

NBY

NovaBay Pharmaceuticals and Eyenovia have started co-promoting eyecare products to ophthalmic surgery centers. Eyenovia's salesforce will promote NovaBay's Avenova and its own MydCombi, while NovaBay prepares for Eyenovia's Clobetasol launch in August 2024.

Portfolio Pulse from Benzinga Newsdesk

July 01, 2024 | 10:55 am

EVEX

Eve Air Mobility (NYSE: EVEX; EVEXW) has secured $94M in equity financing from investors including Embraer and Nidec. This funding will support the development and manufacturing of Eve's eVTOL aircraft.

Portfolio Pulse from Benzinga Newsdesk

July 01, 2024 | 10:52 am

TNXP

Tonix Pharmaceuticals has entered into an agreement with the Defense Threat Reduction Agency for $34 million to develop a broad-spectrum antiviral, TNX-4200, through Phase 1 clinical evaluation.

Portfolio Pulse from Benzinga Newsdesk

July 01, 2024 | 10:50 am

VALN

The European Commission has granted marketing authorization for Valneva's single-dose vaccine, Ixchiq, for individuals 18 years and older. The company expects to deliver the first doses in Europe in Q4 of 2024.

Portfolio Pulse from Benzinga Newsdesk

July 01, 2024 | 10:40 am

OLN

WLK

Olin Corporation and Westlake Corporation, as part of the Ad Hoc Coalition of Epoxy Resin Producers, have prompted the European Commission to initiate an anti-dumping investigation on epoxy resin imports from China, Korea, Taiwan, and Thailand. The investigation aims to determine if these imports have caused material injury to the European epoxy resin industry by being sold at unfairly low prices.

Portfolio Pulse from Benzinga Newsdesk

July 01, 2024 | 10:35 am

SWTX

SpringWorks Therapeutics has submitted a New Drug Application to the FDA for mirdametinib, targeting pediatric and adult patients with Neurofibromatosis Type 1-Associated Plexiform Neurofibromas. The company also plans to file a Marketing Authorization Application with the European Medicines Agency in the second half of 2024.

Portfolio Pulse from Benzinga Newsdesk

July 01, 2024 | 10:32 am

AAPL

AMZN

GOOGL

META

MSFT

NVDA

TSLA

Nvidia Corporation (NASDAQ:NVDA) has seen a 149% stock increase this year, significantly outperforming the S&P 500's 14.5% rise. Investors are flocking to Nvidia due to its strong performance in AI technology, while other sectors in the S&P 500 have declined. The Magnificent Seven, including Nvidia, have driven 60% of the index's total return this year. Analysts are divided on Nvidia's future, with some predicting continued growth and others warning of a potential bubble.

Portfolio Pulse from Benzinga Neuro

July 01, 2024 | 10:23 am